Literature DB >> 2356229

In vivo tests of the concept of photodynamic threshold dose in normal rat liver photosensitized by aluminum chlorosulphonated phthalocyanine.

M S Patterson1, B C Wilson, R Graff.   

Abstract

In its simplest form, the photodynamic therapy (PDT) threshold dose model states that tissue necrosis due to PDT will occur if the number of photons absorbed by the photosensitizer per unit volume of tissue exceeds a critical value. This threshold is given by the product of photon fluence, photosensitizer concentration and specific absorption coefficient. To test the validity of this concept for PDT of normal rat liver sensitized with aluminum chlorosulphonated phthalocyanine (AISPC), all three of these parameters were varied by changing the injected AISPC dose, the wavelength of excitation and the irradiation geometry. The extent of necrosis caused by the treatment was consistent with the threshold model, except when the concentration of AISPC in the liver exceeded 20 micrograms g-1. For this animal model, we estimate the threshold to be (3.8 +/- 0.2) x 10(19) photons cm-3.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2356229     DOI: 10.1111/j.1751-1097.1990.tb01720.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  24 in total

1.  A comparison of novel light sources for photodynamic therapy.

Authors:  M L De Jode; J A McGilligan; M G Dilkes; I Cameron; P B Hart; M F Grahn
Journal:  Lasers Med Sci       Date:  1997-10       Impact factor: 3.161

2.  Implicit and explicit dosimetry in photodynamic therapy: a New paradigm.

Authors:  B C Wilson; M S Patterson; L Lilge
Journal:  Lasers Med Sci       Date:  1997-10       Impact factor: 3.161

3.  How tissue optics affect dosimetry of photodynamic therapy.

Authors:  Steven L Jacques
Journal:  J Biomed Opt       Date:  2010 Sep-Oct       Impact factor: 3.170

4.  A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy.

Authors:  Haixia Qiu; Michele M Kim; Rozhin Penjweini; Jarod C Finlay; Theresa M Busch; Tianhao Wang; Wensheng Guo; Keith A Cengel; Charles B Simone; Eli Glatstein; Timothy C Zhu
Journal:  Photochem Photobiol       Date:  2017-02-22       Impact factor: 3.421

5.  Treatment planning using tailored and standard cylindrical light diffusers for photodynamic therapy of the prostate.

Authors:  Augusto Rendon; J Christopher Beck; Lothar Lilge
Journal:  Phys Med Biol       Date:  2008-02-05       Impact factor: 3.609

Review 6.  The role of photodynamic therapy (PDT) physics.

Authors:  Timothy C Zhu; Jarod C Finlay
Journal:  Med Phys       Date:  2008-07       Impact factor: 4.071

7.  A study of the control of oral plaque biofilms via antibacterial photodynamic therapy.

Authors:  J F Tahmassebi; E Drogkari; S R Wood
Journal:  Eur Arch Paediatr Dent       Date:  2015-09-18

8.  CT contrast predicts pancreatic cancer treatment response to verteporfin-based photodynamic therapy.

Authors:  Michael Jermyn; Scott C Davis; Hamid Dehghani; Matthew T Huggett; Tayyaba Hasan; Stephen P Pereira; Stephen G Bown; Brian W Pogue
Journal:  Phys Med Biol       Date:  2014-03-20       Impact factor: 3.609

9.  Necrosis response to photodynamic therapy using light pulses in the femtosecond regime.

Authors:  Clóvis Grecco; Lilian Tan Moriyama; Alessandro Cosci; Sebastião Pratavieira; Vanderlei Salvador Bagnato; Cristina Kurachi
Journal:  Lasers Med Sci       Date:  2012-10-12       Impact factor: 3.161

10.  A light emitting diode (LED) based spatial frequency domain imaging system for optimization of photodynamic therapy of nonmelanoma skin cancer: quantitative reflectance imaging.

Authors:  R B Saager; D J Cuccia; S Saggese; K M Kelly; A J Durkin
Journal:  Lasers Surg Med       Date:  2013-04       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.